{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:35:03Z","timestamp":1792089303029,"version":"4.4.0"},"reference-count":40,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2018.0429","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T14:47:13Z","timestamp":1529419633000},"source":"Crossref","is-referenced-by-count":83,"title":["Helicobacter Pylori Infection"],"prefix":"10.3238","author":[{"given":"Wolfgang","family":"Fischbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Malfertheiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"key":"10.3238\/arztebl.2018.0429_ref1","doi-asserted-by":"crossref","unstructured":"Warren JR, Marshall BL: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 8390: 1311\u20135.","DOI":"10.1016\/S0140-6736(84)91816-6"},{"key":"10.3238\/arztebl.2018.0429_ref2","doi-asserted-by":"crossref","unstructured":"Sugano K, Tack J, Kuipers EJ, et al.: Kyoto global consensus report on Helicobacter pylori gastritis. Gut 2015; 64: 1353\u201367","DOI":"10.1136\/gutjnl-2015-309252"},{"key":"10.3238\/arztebl.2018.0429_ref3","doi-asserted-by":"crossref","unstructured":"Malfertheiner P, Megraud F, O`Morain CA, et al.: Management of Helicobacter pylori infection \u2013 the Maastricht V\/Florence Consensus report. Gut 2017; 66: 6\u201330","DOI":"10.1136\/gutjnl-2016-312288"},{"key":"10.3238\/arztebl.2018.0429_ref4","doi-asserted-by":"crossref","unstructured":"Fallone CA, Chiba N, van Zanten SV, et al.: The Toronto Consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterol 2016; 151: 51\u201369","DOI":"10.1053\/j.gastro.2016.04.006"},{"key":"10.3238\/arztebl.2018.0429_ref5","doi-asserted-by":"crossref","unstructured":"Fischbach W, Malfertheiner P, Lynen Jansen P, et al.: S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease. Z Gastroenterol 2017; 54: 167\u2013206.","DOI":"10.1055\/s-0042-119653"},{"key":"10.3238\/arztebl.2018.0429_ref6","doi-asserted-by":"crossref","unstructured":"Chen Y, Segers S, Blaser MJ: Association between Helicobacter pylori and mortality in the NHANES III study. Gut 2013; 62: 1262\u20139","DOI":"10.1136\/gutjnl-2012-303018"},{"key":"10.3238\/arztebl.2018.0429_ref7","doi-asserted-by":"crossref","unstructured":"Pan Kf, Zhang L, Gerhard M, et al.: A Large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication. Gut 2016; 65: 9\u201318","DOI":"10.1136\/gutjnl-2015-309197"},{"key":"10.3238\/arztebl.2018.0429_ref8","doi-asserted-by":"crossref","unstructured":"Fischbach W, Malfertheiner P, Hoffmann JC, et al.: S3-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit. Z Gastroenterol 2009; 47: 68\u2013102","DOI":"10.1055\/s-0028-1109062"},{"key":"10.3238\/arztebl.2018.0429_ref9","doi-asserted-by":"crossref","unstructured":"Malfertheiner P, Mossner J, Fischbach W, et al: Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia. Aliment Pharmacol Ther 2003; 18: 615\u201325","DOI":"10.1046\/j.1365-2036.2003.01695.x"},{"key":"10.3238\/arztebl.2018.0429_ref10","doi-asserted-by":"crossref","unstructured":"Moayyedi P, Soo S, Deeks JJ et al.: Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2011; 16(2): CD002096","DOI":"10.1002\/14651858.CD002096.pub5"},{"key":"10.3238\/arztebl.2018.0429_ref11","doi-asserted-by":"crossref","unstructured":"Zhao B, Zhao J, Cheng WF, et al.: Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia. A meta-analysis of randomized controlled studies with 12-month follow- up. J Clin Gastroenterol 2014; 48: 241\u20137","DOI":"10.1097\/MCG.0b013e31829f2e25"},{"key":"10.3238\/arztebl.2018.0429_ref12","doi-asserted-by":"crossref","unstructured":"Gisbert JP, Pajares JM: C-urea breath test in the diagnosis of Helicobacter pylori infection \u2013 a critical review. Aliment Pharmacol Ther 2004; 20: 1001\u201317","DOI":"10.1111\/j.1365-2036.2004.02203.x"},{"key":"10.3238\/arztebl.2018.0429_ref13","doi-asserted-by":"crossref","unstructured":"Gisbert JP, de la MF, Abraira V: Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and metaanalysis. Am J Gastroenterol 2006; 101: 1921\u201330","DOI":"10.1111\/j.1572-0241.2006.00668.x"},{"key":"10.3238\/arztebl.2018.0429_ref14","doi-asserted-by":"crossref","unstructured":"Best LMJ, Takwoingi Y, Siddique S, et al.: Non-invasive diagnostic tests for Helicobacter pylori infection. Cochrane Database of Syst Rev 2018, CD012080","DOI":"10.1002\/14651858.CD012080.pub2"},{"key":"10.3238\/arztebl.2018.0429_ref15","doi-asserted-by":"crossref","unstructured":"Dinis-Ribeiro M, Areia M, de Vries AC, et al.: Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44: 74\u201394.","DOI":"10.1055\/s-0031-1291491"},{"key":"10.3238\/arztebl.2018.0429_ref16","doi-asserted-by":"crossref","unstructured":"M\u00f6ssner J: The indications, applications, and risks of proton pump inhibitors\u2014a review after 25 years. Dtsch Arztebl Int 2016; 113: 477\u201383","DOI":"10.3238\/arztebl.2016.0477"},{"key":"10.3238\/arztebl.2018.0429_ref17","doi-asserted-by":"crossref","unstructured":"Huang JQ, Sridhar S, Hunt RH: Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a metaanalysis. Lancet 2002; 359: 14\u201322","DOI":"10.1016\/S0140-6736(02)07273-2"},{"key":"10.3238\/arztebl.2018.0429_ref18","doi-asserted-by":"crossref","unstructured":"Vergara M, Catalan M, Gisbert JP, Calvet X: Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Ther 2005; 21: 1411\u20138","DOI":"10.1111\/j.1365-2036.2005.02444.x"},{"key":"10.3238\/arztebl.2018.0429_ref19","doi-asserted-by":"crossref","unstructured":"Chan FKL, Ching JYL, Suen BY, et al.: Effects of Helicobacter pylori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin users. Gastroenterol 2013; 144: 528\u201335","DOI":"10.1053\/j.gastro.2012.12.038"},{"key":"10.3238\/arztebl.2018.0429_ref20","doi-asserted-by":"crossref","unstructured":"Lai KC, Lam SK, Chu KM, et al.: Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users\u2013a randomized trial. Aliment Pharmacol Ther 2003; 18: 829\u201336","DOI":"10.1046\/j.1365-2036.2003.01762.x"},{"key":"10.3238\/arztebl.2018.0429_ref21","doi-asserted-by":"crossref","unstructured":"Lundell L, Vieth M, Gibson F, et al.: Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology. Aliment Pharmacol Ther 2015; 42: 649\u201363","DOI":"10.1111\/apt.13324"},{"key":"10.3238\/arztebl.2018.0429_ref22","doi-asserted-by":"crossref","unstructured":"Yang HB, Sheu BS, Wang ST, et al.: H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole. Am J Gastroenterol 2009; 104: 1642\u20139","DOI":"10.1038\/ajg.2009.172"},{"key":"10.3238\/arztebl.2018.0429_ref23","doi-asserted-by":"crossref","unstructured":"Cheung KS, Chan EW, Wong AYS, et al.: Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study. Gut 2018; 67: 28\u201335","DOI":"10.1136\/gutjnl-2017-314605"},{"key":"10.3238\/arztebl.2018.0429_ref24","doi-asserted-by":"crossref","unstructured":"Ford AC, Forman D, Hunt RH, et al.: Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ 2014; 348: 3174","DOI":"10.1136\/bmj.g3174"},{"key":"10.3238\/arztebl.2018.0429_ref25","doi-asserted-by":"crossref","unstructured":"Wong BC, Lam SK, Wong WM, et al.: Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187\u201394","DOI":"10.1001\/jama.291.2.187"},{"key":"10.3238\/arztebl.2018.0429_ref26","doi-asserted-by":"crossref","unstructured":"Shiotani A, Uedo N, Iishi H, et al.: Predictive factors for metachronous gastric cancer in high- risk patients after successful Helicobacter pylori eradication. Digestion 2008; 78: 113\u20139","DOI":"10.1159\/000173719"},{"key":"10.3238\/arztebl.2018.0429_ref27","unstructured":"Correa, P: Human gastric carcinogenesis: a multistep and multifactorial process\u2014first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52: 6735\u201340"},{"key":"10.3238\/arztebl.2018.0429_ref28","doi-asserted-by":"crossref","unstructured":"Maehata Y, Nakamura S, Fujisawa K, et al.: Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc 2012; 75: 39\u201346","DOI":"10.1016\/j.gie.2011.08.030"},{"key":"10.3238\/arztebl.2018.0429_ref29","doi-asserted-by":"crossref","unstructured":"Fukase K, Kato M, Kikuchi S, et al.: Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open- label, randomised controlled trial. Lancet 2008; 372: 392\u20137","DOI":"10.1016\/S0140-6736(08)61159-9"},{"key":"10.3238\/arztebl.2018.0429_ref30","doi-asserted-by":"crossref","unstructured":"Kwon YH, Heo J, Lee HS, et al.: Failure of Helicobacter pylori eradication and age are independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer in 283 patients. Aliment Pharmacol Ther 2014; 39: 609\u201318","DOI":"10.1111\/apt.12633"},{"key":"10.3238\/arztebl.2018.0429_ref31","unstructured":"Seo JY, Lee DH, Cho Y, et al.: Eradication of Helicobacter pylori reduces metachronous gastric cancer after endoscopic resection of early gastric cancer. Hepatogastroenterology 2013; 60: 776\u201380"},{"key":"10.3238\/arztebl.2018.0429_ref32","doi-asserted-by":"crossref","unstructured":"Toyokawa T, Suwaki K, Miyake Y, et al.: Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study. J Gastroenterol Hepatol 2010; 25: 544\u20137","DOI":"10.1111\/j.1440-1746.2009.05995.x"},{"key":"10.3238\/arztebl.2018.0429_ref33","doi-asserted-by":"crossref","unstructured":"Li WQ, Ma JL, Zhang L, et al.: Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. J Natl Cancer Inst 2014;106: dju116","DOI":"10.1093\/jnci\/dju352"},{"key":"10.3238\/arztebl.2018.0429_ref34","doi-asserted-by":"crossref","unstructured":"Choi IJ, Kook MC, Kim YI, et al.: Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med 2018; 378: 1085\u201395","DOI":"10.1056\/NEJMoa1708423"},{"key":"10.3238\/arztebl.2018.0429_ref35","doi-asserted-by":"crossref","unstructured":"Lee YC, Chiang TH, Chou CK, et al.: Association Between Helicobacter pylori eradication and gastric cancer incidence: A systematic review and metaanalysis. Gastroenterol 2016; 150: 1113\u201324","DOI":"10.1053\/j.gastro.2016.01.028"},{"key":"10.3238\/arztebl.2018.0429_ref36","doi-asserted-by":"crossref","unstructured":"Shichijo S, Hirata Y, Nikura R, et al.: Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. Gastrointest Endosc 2016; 84: 618\u201324","DOI":"10.1016\/j.gie.2016.03.791"},{"key":"10.3238\/arztebl.2018.0429_ref37","doi-asserted-by":"crossref","unstructured":"Li BZ, Threapleton DE, Wang JY, et al.: Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis. BMJ 2015; 351: h4052","DOI":"10.1136\/bmj.h4052"},{"key":"10.3238\/arztebl.2018.0429_ref38","doi-asserted-by":"crossref","unstructured":"Megraud F, Coenen S, Versporten A, et al.: (Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2013; 62: 34\u201342","DOI":"10.1136\/gutjnl-2012-302254"},{"key":"10.3238\/arztebl.2018.0429_ref39","doi-asserted-by":"crossref","unstructured":"Selgrad M, Meile J, Bornschein J, et al.: Antibiotic susceptibility of Helicobacter pylori in central Germany and its relationship with the number of eradication therapies. Eur J Gastroenterol Hepatol 2013; 25: 1257\u201360","DOI":"10.1097\/MEG.0b013e3283643491"},{"key":"10.3238\/arztebl.2018.0429_ref40","doi-asserted-by":"crossref","unstructured":"McFarland LV, Huang Y, Wang L, Malfertheiner P: Systematic review and meta-analysis: multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events. United European Gastroenterol J 2016; 4: 546\u201361.","DOI":"10.1177\/2050640615617358"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2018.0429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T13:46:51Z","timestamp":1638798411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2018.0429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,22]]},"references-count":40,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2018.0429","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,22]]}}}